Turning Poo Into Insights.

We aspire to build the Poodl.

A portable scanner for monitoring the quality of digestion and detecting health states that correspond with changes in the stool. A convenient and easy-to-use home-monitoring solution combined with tele-health services. 

After promising feasibility studies, we currently identify the most promising target population and will start validation studies soon.

Problem

A healthy bowel takes it all. Otherwise, something is wrong.
bad quality of digestion is a sign for:

  • Malabsorption and / or Maldigestion due to:

    • Inflammation  or Irritation of the bowel 

    • Short Bowel Syndrome / Celiac disease / Pancreatic insufficiency / Lack of bile acids

  • Change in Nutrition (e.g. High Protein Diet)

  • Unsuitable Enteral Nutrition (e.g. after an accident)

also neurological or neurodegenerative diseases such as Alzheimer´s Disease, Multiples Sclerosis, or Depression are associated with the bowel.

Market Potential

  • More than 1.4 million people in Germany, primarily women, are diagnosed with Irritable Bowel Syndrom or Inflammatory Bowel Disease. 7-16% of the total population struggles with symptoms of an Irritable Bowel Syndrom, a similar prevalence for Europe and the United States.
  • Overall annual healthcare expenditures in U.S. for gastrointestinal disease total $136 billion. 
  • Abdominal pain is the symptom most responsible for 22 million office visits and 6 million emergency department (ED) visits in the U.S.
  • There is an $18 billion market forecast for IoT & diagnostics by 2020 according to Forbes.
  • US market research analysts estimate the stool testing market to surpass US$ 720 million by 2019 due to the growing awareness of diagnostic stool test among the people.

Outcomes

  • Qualification & Quantification of scientific parameter & pattern
  • Objective data for the user, patient or healthcare professionals
  • Enabling personalized therapy
  • Nutrition optimization or diet adjustment

  • Increase Quality of Life (QoL), the energy level and productivity for patients
  • Avoiding painful phases of patients
  • Reduction of Healthcare burdens & hospitalization costs
  • Reduction of steroids like cortisone.

Potential Customers

  • People who suffer from gastrointestinal diseases, like Inflammatory bowel disease or Irritable bowel syndrome, who want more insights about their digestive health and want to home-monitor their stool
  • Parents who wish to gain insights into their child’s digestive health
  • Providers who want to personalize enteral nutrition for patients
  • Payers which want to avoid hospitalization costs and allocate resources more effective

Our Call


We are raising, get in touch: hello@poodl.io
20% refund of your investement by BAFA

Crew

Lutz Haase, MBA
Founder & CEO

10+ years of digital health consulting for e.g. Bayer, Biotronik or Roche Diagnostics. Angel Investor.

Dr. Jan Kunde
Founder & CSO

15+ years of medical affairs within Bayer, Thermo Fisher Scientific, Takeda or Epigenomics.

Dr. Hardy Kietzmann
(Advisor)

20+ years in Healthcare & Pharma in the fields of innovation, business development and strategy.

Prof. Dr. Andreas Schwiertz (Advisor)

Head of R&D at MVZ Institute of Microecology & Microbiome Expert

Partner

Institute of Microecology
The specialist for microbiota and mucosal surface.

Partner

Center for biomedical image and information processing
HTW Berlin

“In 30 years from now, people will say: What?! You didn’t measure your poo regularly?!”